Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Annexon (NASDAQ:ANNX)

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants - Annexon (NASDAQ:ANNX)

BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. ("Annexon") (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the pricing of its previously announced underwritten public offering of 25,096,153 shares of its common stock at a price to the public of $2.60 per share and, in li…

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation...

Annexon (NASDAQ: ANNX) prices $75M stock and pre-funded warrants offering, 30-day option

Annexon priced 25,096,153 shares at $2.60 and 3,750,000 pre-funded warrants at $2.599 ($0.001 exercise). Gross proceeds $75M; closing Nov 14, 2025.